AbbVie | La Marge Brute Sur Les Ventes



Gross Profit On Sales Changement Date
AbbVie USD 9.34B 1.36B 2025-03
Abbott USD 5.87B 50M 2025-06
ALKERMES USD 257.77M 462K 2025-06
Amgen USD 6.17B 624M 2025-06
AstraZeneca USD 11.98B 637M 2025-06
Biogen USD 2.04B 238.8M 2025-06
BioMarin Pharmaceutical USD 670.47M 76.89M 2025-06
Bristol-Myers Squibb USD 8.9B 714M 2025-06
Eisai JPY 160.05B 12.42B 2025-06
Eli Lilly USD 13.11B 2.61B 2025-06
Gilead Sciences USD 5.58B 453M 2025-06
GlaxoSmithKline GBP 5.82B 229M 2025-06
J&J USD 14.6B 816M 2025-03
Medtronic USD 5.12B 695M 2025-07
Merck USD 12.99B 224M 2025-06
Neurocrine Biosciences USD 676.2M 112.8M 2025-06
Novartis USD 11.51B 1.12B 2025-06
Pacira USD 125.91M 8.71M 2025-06
Perrigo USD 362.9M 29.4M 2025-06
Pfizer USD 10.88B 248M 2025-06
Regeneron Pharmaceuticals USD 3.15B 581M 2025-06
Roche Holding CHF 11.69B 48M 2024-12
Sanofi EUR 7.74B 26M 2025-06
UCB EUR 2.46B 520M 2024-12
Ultragenyx Pharmaceutical USD 143.49M 32.86M 2025-06
United Therapeutics USD 711M 9.1M 2025-06
Vertex Pharmaceuticals USD 2.56B 150M 2025-06
Zoetis USD 1.78B 180M 2025-06


AbbVie La Marge Brute Sur Les Ventes - Les valeurs actuelles, des données historiques, des prévisions, des statistiques, des tableaux et le calendrier économique - Aug 2025.